Erratum: Wang L, Man N, Sun X-J, et al. Regulation of AKT signaling by Id1 controls t(8;21) leukemia initiation and progression. Blood. 2015;126(5):640-650

DOI: https://doi.org/10.1182/blood-2016-03-703744

IF: 20.3

2016-04-14

Blood

Abstract:[This corrects the article DOI: 10.1182/blood-2015-03-635532.].

What problem does this paper attempt to address?

Author Correction: Targeted Inhibition of STAT/TET1 Axis As a Therapeutic Strategy for Acute Myeloid Leukemia

Xi Jiang,Chao Hu,Kyle Ferchen,Ji Nie,Xiaolong Cui,Chih-Hong Chen,Liting Cheng,Zhixiang Zuo,William Seibel,Chunjiang He,Yixuan Tang,Jennifer R. Skibbe,Mark Wunderlich,William C. Reinhold,Lei Dong,Chao Shen,Stephen Arnovitz,Bryan Ulrich,Jiuwei Lu,Hengyou Weng,Rui Su,Huilin Huang,Yungui Wang,Chenying Li,Xi Qin,James C. Mulloy,Yi Zheng,Jiajie Diao,Jie Jin,Chong Li,Paul P. Liu,Chuan He,Yuan Chen,Jianjun Chen

DOI: https://doi.org/10.1038/s41467-018-02947-0

IF: 16.6

2018-01-01

Nature Communications

Abstract:The original version of this Article contained an error in the spelling of the author James C. Mulloy, which was incorrectly given as James Mulloy. This has now been corrected in both the PDF and HTML versions of the Article.
Correction: the Combination Effect of Homoharringtonine and Ibrutinib on FLT3-ITD Mutant Acute Myeloid Leukemia

Xia Li,Xiufeng Yin,Huafeng Wang,Jiansong Huang,Mengxia Yu,Zhixin Ma,Chenying Li,Yile Zhou,Xiao Yan,ShuJuan Huang,Jie Jin

DOI: https://doi.org/10.18632/oncotarget.27310

2019-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.14463.].
Erratum: Sun C, Tian X, Lee YS, et al. Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib. Blood. 2015;126(19):2213-2219

DOI: https://doi.org/10.1182/blood-2016-06-725010

IF: 20.3

2016-08-18

Blood

Abstract:[This corrects the article DOI: 10.1182/blood-2015-04-639203.].
Erratum: Epigenomic characterization of a p53-regulated 3p22.2 tumor suppressor that inhibits STAT3 phosphorylation via protein docking and is frequently methylated in esophageal and other carcinomas: Erratum.

Lili Li,Juan Xu,Guohua Qiu,Jianming Ying,Zhenfang Du,Tingxiu Xiang,Kai Yau Wong,Gopesh Srivastava,Xiao-Feng Zhu,Tony S Mok,Anthony Tc Chan,Francis Kl Chan,Richard F Ambinder,Qian Tao

DOI: https://doi.org/10.7150/thno.70351

IF: 11.6

2022-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.20893.].
Erratum: Kini Bailur J, Mehta S, Zhang L, et al. Changes in bone marrow innate lymphoid cell subsets in monoclonal gammopathy: target for IMiD therapy. Blood Adv. 2017;1(25):2343-2347

DOI: https://doi.org/10.1182/bloodadvances.2017015438

2018-01-09

Abstract:[This corrects the article DOI: 10.1182/bloodadvances.2017012732.].
Myeloid cell-derived LL-37 promotes lung cancer growth by activating Wnt/β-catenin signaling: Erratum

Ping Ji,Yongxin Zhou,Yibao Yang,Junlu Wu,Hao Zhou,Wenqiang Quan,Junjun Sun,Yiwen Yao,Anquan Shang,Chenzheng Gu,Bingjie Zeng,Jenni Firrman,Weidong Xiao,Robert Bals,Zujun Sun,Dong Li

DOI: https://doi.org/10.7150/thno.82877

IF: 11.6

2023-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.30726.].

medicine, research & experimental
Correction: Corrigendum: Inhibitory Receptors Bind ANGPTLs and Support Blood Stem Cells and Leukaemia Development

Junke Zheng,Masato Umikawa,Changhao Cui,Jiyuan Li,Xiaoli Chen,Chaozheng Zhang,HoangDinh Huynh,Xunlei Kang,Robert Silvany,Xuan Wan,Jingxiao Ye,Alberto Puig Cantó,Shu-Hsia Chen,Huan-You Wang,E. Sally Ward,Cheng

DOI: https://doi.org/10.1038/nature11268

IF: 64.8

2012-01-01

Nature

Abstract:Nature 485, 656–660 (2012); doi:10.1038/nature11095 The surname of author HoangDinh Huynh was inadvertently misspelled as Hyunh. This has been corrected online in the PDF and HTML of the original paper.
Corrigendum to “PIPKIγ Regulates CCL2 Expression in Colorectal Cancer by Activating AKT-STAT3 Signaling”

JunLi Xue,XiaoXiao Ge,Wei Zhao,Liqiong Xue,Congqi Dai,Fengjuan Lin,Wei Peng

DOI: https://doi.org/10.1155/2020/1786505

IF: 4.4929

2020-09-26

Journal of Immunology Research

Abstract:[This corrects the article DOI: 10.1155/2019/3690561.].

immunology
Erratum: Targeting Telomere Dynamics as an Effective Approach for the Development of Cancer Therapeutics [Corrigendum]

DOI: https://doi.org/10.2147/IJN.S500182

2024-10-14

Abstract:[This corrects the article DOI: 10.2147/IJN.S448556.].
Corrigendum: Regulation of microrna-497-targeting AKT2 influences tumor growth and chemoresistance to cisplatin in lung cancer

Lin Wang,Xiang-Bo Ji,Li-Hong Wang,Jian-Ge Qiu,Feng-Mei Zhou,Wen-Jing Liu,Di-di Wan,Marie Chai-mi Lin,Ling-Zhi Liu,Jian-Ying Zhang,Bing-Hua Jiang

DOI: https://doi.org/10.3389/fcell.2022.1008088

IF: 5.5

2022-09-23

Frontiers in Cell and Developmental Biology

Abstract:[This corrects the article DOI: 10.3389/fcell.2020.00840.].

cell biology,developmental biology
Activation of the PI3K/Akt/mTOR/p70S6K Pathway is Involved in S100A4-Induced Viability and Migration in Colorectal Cancer Cells: Erratum

Haiyan Wang,Liang Duan,Zhengyu Zou,Huan Li,Shimei Yuan,Xian Chen,Yunyuan Zhang,Xueru Li,Hui Sun,He Zha,Yan Zhang,Lan Zhou

DOI: https://doi.org/10.7150/ijms.69070

2022-01-01

International Journal of Medical Sciences

Abstract:[This corrects the article DOI: 10.7150/ijms.8128.].

medicine, general & internal
Erratum: Parry EM, Alder JK, Qi X, Chen JJ-L, Armanios M. Syndrome complex of bone marrow failure and pulmonary fibrosis predicts germline defects in telomerase. Blood. 2011;117(21):5607-5611

DOI: https://doi.org/10.1182/blood-2016-02-700880

IF: 20.3

2016-04-07

Blood

Abstract:[This corrects the article DOI: 10.1182/blood-2010-11-322149.].
Erratum: the PI 3-Kinase/akt Signaling Pathway is Activated Due to Aberrant Pten Expression and Targets Transcription Factors NF-κB and C-Myc in Pancreatic Cancer Cells

Takayuki Asano,Yixin Yao,Jun Zhu,Donghui Li,James L. Abbruzzese,Sujan Reddy

DOI: https://doi.org/10.1038/sj.onc.1208766

IF: 8.756

2005-01-01

Oncogene

Abstract:Correction to: Oncogene (2004) 23, 8571–8580. doi:10.1038/sj.onc.1207902 Due to a typesetting error, Figure 6c of this paper contained an incorrect legend. The figure with the correct legend is given here.
Erratum: STAT3 selectively interacts with Smad3 to antagonize TGF-β signalling

G Wang,Y Yu,C Sun,T Liu,T Liang,L Zhan,X Lin,X-H Feng

DOI: https://doi.org/10.1038/onc.2016.145

IF: 8.756

2016-01-01

Oncogene

Abstract:Correction to: Oncogene (2015) 00, 1–11; doi:10.1038/onc.2015.446; published online 30 November 2015 Following the online publication of this article, it was noted that the final word ‘signalling’ had been erroneously missed off the title. The title has now been rectified. The authors apologise for any inconvenience caused by this error.
Erratum: ITGA2 Overexpression Promotes Esophageal Squamous Cell Carcinoma Aggression via FAK/AKT Signaling Pathway [Corrigendum]

DOI: https://doi.org/10.2147/OTT.S390829

2022-09-27

Abstract:[This corrects the article DOI: 10.2147/OTT.S302028.].
Corrigendum: Downregulation of GLYAT Facilitates Tumor Growth and Metastasis and Poor Clinical Outcomes Through the PI3K/AKT/Snail Pathway in Human Breast Cancer

Xin Tian,Lina Wu,Min Jiang,Zhenyong Zhang,Rong Wu,Jianing Miao,Caigang Liu,Song Gao

DOI: https://doi.org/10.3389/fonc.2022.793448

IF: 4.7

2022-04-06

Frontiers in Oncology

Abstract:[This corrects the article DOI: 10.3389/fonc.2021.641399.].

oncology
[Corrigendum] Role of 4‑aminobutyrate Aminotransferase (ABAT) and the Lncrna Co‑expression Network in the Development of Myelodysplastic Syndrome

Yanzhen Chen,Guangjie Zhao,Nianyi Li,Hongguang Luo,Xiaoqin Wang,Jingwen Gu

DOI: https://doi.org/10.3892/or.2022.8447

2022-01-01

Oncology Reports

Abstract:Subsequently to the publication of the above article, and a Corrigendum that has already been published with the intention of showing corrected versions of Figs. 1 and 8 (DOI: 10.3892/or.2022.8348; published online on June 14, 2022), the authors have belatedly realized that the revisions made to Fig. 8 necessitated changes that should have been introduced into Fig. 9, although these were not attended to in the first corrigendum. Essentially, Fig. 8 was revised as the cell apoptosis and cell proliferation assays therein were poorly presented, which made the interpretation of the data difficult; Fig. 9 showed the fractions of apoptotic cells in the SKM‑1 and THP‑1 cell lines with lncENST00000444102 overexpression as this pertained to Fig. 8. A revised version of Fig. 9, presenting the analysis of the data shown in the revised version of Fig. 8, is shown opposite. In addition to the revision of Fig. 9, the sentence starting on p. 517, left‑hand column, line 12 [“The flow cytometric apoptosis assay revealed that lncENST00000444102 overexpression promoted tumor cells to undergo apoptosis compared to control cells (P<0.001, Fig. 9)”] should be replaced with the following text, to reflect the change in the level of statistical significance: ‘The flow cytometric apoptosis assay revealed that lncENST00000444102 overexpression promoted tumor cells to undergo apoptosis compared to control cells (P<0.01, Fig. 9)”. Note that the revisions made to Figs. 8 and 9 in this paper have not had a major impact on the reported results, and do not affect the overall conclusions reported in the study. All the authors agree to the publication of this corrigendum. The authors are grateful to the Editor of Oncology Reports for allowing them the opportunity to publish this additional Corrigendum; furthermore, they apologize for any inconvenience caused to the readership of the Journal. [Oncology Reports 42: 509‑520, 2019; DOI: 10.3892/or.2019.7175]
Correction: Regulation of tumor suppressor EAF2 polyubiquitination by ELL1 and SIAH2 in prostate cancer cells.

Xinpei Yu,Junkui Ai,Liquan Cai,Yifeng Jing,Dan Wang,Jun Dong,Laura E Pascal,Jian Zhang,Rongcheng Luo,Zhou Wang

DOI: https://doi.org/10.18632/oncotarget.27354

2019-01-01

Oncotarget

Abstract:[This corrects the article DOI: 10.18632/oncotarget.8588.].
Erratum: Alkaline Phosphatase Controls Lineage Switching of Mesenchymal Stem Cells by Regulating the LRP6/GSK3β Complex in Hypophosphatasia: Erratum.

Wenjia Liu,Liqiang Zhang,Kun Xuan,Chenghu Hu,Liya Li,Yongjie Zhang,Fang Jin,Yan Jin

DOI: https://doi.org/10.7150/thno.103686

IF: 11.6

2024-01-01

Theranostics

Abstract:[This corrects the article DOI: 10.7150/thno.27372.].
Erratum: KLF10 inhibits cell growth by regulating PTTG1 in multiple myeloma under the regulation of microRNA-106b-5p: Erratum.

Mimi Zhou,Jinqiu Chen,Hui Zhang,Hailing Liu,Huan Yao,Xiaman Wang,Wanggang Zhang,Yingren Zhao,Nan Yang

DOI: https://doi.org/10.7150/ijbs.77067

2022-01-01

International Journal of Biological Sciences

Abstract:[This corrects the article DOI: 10.7150/ijbs.45999.].

Erratum: Wang L, Man N, Sun X-J, et al. Regulation of AKT signaling by Id1 controls t(8;21) leukemia initiation and progression. Blood. 2015;126(5):640-650

Author Correction: Targeted Inhibition of STAT/TET1 Axis As a Therapeutic Strategy for Acute Myeloid Leukemia

Correction: the Combination Effect of Homoharringtonine and Ibrutinib on FLT3-ITD Mutant Acute Myeloid Leukemia

Erratum: Sun C, Tian X, Lee YS, et al. Partial reconstitution of humoral immunity and fewer infections in patients with chronic lymphocytic leukemia treated with ibrutinib. Blood. 2015;126(19):2213-2219

Erratum: Epigenomic characterization of a p53-regulated 3p22.2 tumor suppressor that inhibits STAT3 phosphorylation via protein docking and is frequently methylated in esophageal and other carcinomas: Erratum.

Erratum: Kini Bailur J, Mehta S, Zhang L, et al. Changes in bone marrow innate lymphoid cell subsets in monoclonal gammopathy: target for IMiD therapy. Blood Adv. 2017;1(25):2343-2347

Myeloid cell-derived LL-37 promotes lung cancer growth by activating Wnt/β-catenin signaling: Erratum

Correction: Corrigendum: Inhibitory Receptors Bind ANGPTLs and Support Blood Stem Cells and Leukaemia Development

Corrigendum to “PIPKIγ Regulates CCL2 Expression in Colorectal Cancer by Activating AKT-STAT3 Signaling”

Erratum: Targeting Telomere Dynamics as an Effective Approach for the Development of Cancer Therapeutics [Corrigendum]

Corrigendum: Regulation of microrna-497-targeting AKT2 influences tumor growth and chemoresistance to cisplatin in lung cancer

Activation of the PI3K/Akt/mTOR/p70S6K Pathway is Involved in S100A4-Induced Viability and Migration in Colorectal Cancer Cells: Erratum

Erratum: Parry EM, Alder JK, Qi X, Chen JJ-L, Armanios M. Syndrome complex of bone marrow failure and pulmonary fibrosis predicts germline defects in telomerase. Blood. 2011;117(21):5607-5611

Erratum: the PI 3-Kinase/akt Signaling Pathway is Activated Due to Aberrant Pten Expression and Targets Transcription Factors NF-κB and C-Myc in Pancreatic Cancer Cells

Erratum: STAT3 selectively interacts with Smad3 to antagonize TGF-β signalling

Erratum: ITGA2 Overexpression Promotes Esophageal Squamous Cell Carcinoma Aggression via FAK/AKT Signaling Pathway [Corrigendum]

Corrigendum: Downregulation of GLYAT Facilitates Tumor Growth and Metastasis and Poor Clinical Outcomes Through the PI3K/AKT/Snail Pathway in Human Breast Cancer

[Corrigendum] Role of 4‑aminobutyrate Aminotransferase (ABAT) and the Lncrna Co‑expression Network in the Development of Myelodysplastic Syndrome

Correction: Regulation of tumor suppressor EAF2 polyubiquitination by ELL1 and SIAH2 in prostate cancer cells.

Erratum: Alkaline Phosphatase Controls Lineage Switching of Mesenchymal Stem Cells by Regulating the LRP6/GSK3β Complex in Hypophosphatasia: Erratum.

Erratum: KLF10 inhibits cell growth by regulating PTTG1 in multiple myeloma under the regulation of microRNA-106b-5p: Erratum.